Park Avenue Securities’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Buy
5,179
+276
+6% +$72.6K 0.01% 795
2026
Q1
$1.31M Buy
4,903
+60
+1% +$16.2K 0.01% 703
2025
Q4
$1.22M Sell
4,843
-486
-9% -$129K 0.01% 719
2025
Q3
$1.53M Sell
5,329
-515
-9% -$138K 0.01% 697
2025
Q2
$1.53M Sell
5,844
-1,300
-18% -$317K 0.01% 611
2025
Q1
$1.66M Buy
7,144
+619
+9% +$150K 0.02% 449
2024
Q4
$1.5M Buy
6,525
+1,205
+23% +$276K 0.02% 582
2024
Q3
$1.19M Buy
+5,320
New +$1.17M 0.01% 607
2024
Q2
Sell
-5,497
Closed -$1.2M 1393
2024
Q1
$1.2M Sell
5,497
-3,673
-40% -$809K 0.02% 584
2023
Q4
$2.08M Sell
9,170
-943
-9% -$198K 0.03% 367
2023
Q3
$2.03M Buy
+10,113
New +$2.13M 0.03% 329
2023
Q1
Sell
-9,435
Closed -$1.91M 962
2022
Q4
$1.91M Buy
9,435
+44
+0.5% +$8.6K 0.03% 319
2022
Q3
$1.65M Buy
9,391
+649
+7% +$133K 0.03% 306
2022
Q2
$1.76M Buy
8,742
+1,111
+15% +$237K 0.03% 297
2022
Q1
$1.73M Buy
7,631
+898
+13% +$211K 0.03% 317
2021
Q4
$1.82M Buy
6,733
+1,138
+20% +$282K 0.03% 294
2021
Q3
$1.35M Buy
5,595
+633
+13% +$160K 0.03% 324
2021
Q2
$1.18M Buy
4,962
+754
+18% +$172K 0.03% 337
2021
Q1
$922K Buy
4,208
+1,253
+42% +$251K 0.02% 372
2020
Q4
$517K Buy
2,955
+555
+23% +$95.9K 0.01% 490
2020
Q3
$388K Buy
2,400
+534
+29% +$84.6K 0.01% 502
2020
Q2
$266K Buy
+1,866
New +$258K 0.01% 541
2020
Q1
Sell
-1,488
Closed -$216K 465
2019
Q4
$216K Buy
+1,488
New +$215K 0.01% 554
2019
Q1
Sell
-2,117
Closed -$240K 480
2018
Q4
$240K Sell
2,117
-502
-19% -$67.2K 0.04% 138
2018
Q3
$390K Buy
+2,619
New +$398K 0.06% 102

Other funds holding LH

Park Avenue Securities's LH Position: Q2 2026 in Review

Park Avenue Securities increased its Labcorp (LH) stake by 5.6% in Q2 2026, buying an estimated $72.6K and bringing the position to 5,179 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #795.

Park Avenue Securities first reported a position in LH in Q3 2018 and has held it in 25 quarters since. The position peaked at $2.08M in Q4 2023. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Park Avenue Securities held 5,179 shares of Labcorp worth $1.45M as of Q2 2026.
  • Park Avenue Securities bought 276 Labcorp shares in Q2 2026, an estimated $72.6K.
  • Labcorp made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #795 holding.
  • Park Avenue Securities first reported a position in Labcorp in Q3 2018 and has held it in 25 quarters since.
  • Park Avenue Securities's Labcorp position peaked at $2.08M in Q4 2023.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.